expiredmixedyoutube

Autoimmune Encephalitis Round 2: Electric Boogaloo

Small Nasdaq-100 dip is buyable; maintain risk-on exposure. The author experienced a personal health setback (autoimmune encephalitis flare) but observed only a modest market pullback and recommends a mixed, risk-on response anchored to Nasdaq-100 exposure.

Confidence
35 / 100
Assets
3
Authors
1
Outcome
successful

Linked assets

Primary instruments referenced: QQQ as a clean, liquid Nasdaq-100 proxy for a modest dip-buy/hold-through-bounce; TQQQ for higher-volatility, leveraged upside if the rebound is quick; SQQQ as the inverse -3x product that would likely lose if the dip-buy succeeds.

QQQInvesco QQQ Trust, Series 1buysuccessful

The composition and weighting of the securities portion of a portfolio deposit are also adjusted to conform to changes in the index.

Confidence: 40 / 100Start: $601.30Latest: $644.33Return: 7.16%

Clean, liquid proxy for the implied Nasdaq exposure; fits a modest dip-buy/hold-through-bounce setup.

TQQQProShares UltraPro QQQbuysuccessful

ProShares UltraPro QQQ (TQQQ) is a leveraged exchange-traded fund seeking three times the daily performance of the Nasdaq-100 Index.

Confidence: 32 / 100Start: $48.35Latest: $57.40Return: 18.72%

Higher-vol expression; only appropriate if the dip truly is small and a rebound is expected quickly.

SQQQProShares UltraPro Short QQQsellsuccessful

ProShares UltraPro Short QQQ (SQQQ) is an exchange-traded fund providing -3x daily exposure to the Nasdaq-100 Index.

Confidence: 28 / 100Start: $72.96Latest: $57.59Return: 21.07%

Inverse instrument would likely be hurt if the implied dip-buy bounce occurs.

Source proof

Source proof: Strong source proof | 3 directional assets | 1 supporting author | 3 successful tracked legs | headline-like title review

Most referenced source content is promotional, containing legal/affiliate disclaimers and product links (YouTube/X/Discord/Autopilot). Only one post provides market-relevant content: a brief personal update describing hospitalization for an autoimmune encephalitis flare and a short market comment characterizing the morning as a “red morning” but only a “tiny dip” in the author’s Nasdaq exposure—implicitly supporting a dip-buy/hold stance. Other linked posts are promotional or non-substantive for market analysis.

SpaceX IPO: T-1 to Rugpull
InTheMoney · Jun 10, 2026, 7:30 AM EDT

The provided body contains promotional links and general investing disclaimers, with no substantive analysis or concrete, tradable information about a SpaceX IPO beyond the sensational title (“T-1 to Rugpull”). As a result, actionable signals, catalysts, timing, and tickers are largely absent.

View source
The Space X IPO is NOT Chill - A Channel Update
InTheMoney · Jun 5, 2026, 11:22 AM EDT

The provided source contains only a title and repeats it in the body, with no additional details, data, timing, or claims. It mentions SpaceX and an IPO but provides no actionable information for trading or thesis construction.

View source
Why SoFi Ain’t It
InTheMoney · Jun 3, 2026, 4:02 PM EDT

The source is a largely incoherent rant centered on a bearish view of SoFi (SOFI), referencing short interest/shorting, and mentions buying puts and briefly buying the Vanguard Growth ETF (VUG). It lacks concrete catalysts, numbers, timing, or a clear repeatable setup beyond a general “short/puts” posture on SOFI.

View source
Why SoFi Ain’t It
InTheMoney · Jun 3, 2026, 12:37 PM EDT

Why SoFi Ain’t It subscriptions revenue top's going up earnings comes around and um we won't shorts and so they're going to you know find companies to short but if you look at the short interest it's like 15% cost you're buying into a stock where we legitimate and then the the stock moons then everyone drops a stock like it's getting [ __ ] like 10 calls in a row than get spam calls from somebody from a bubbles. SL AI on the banking. What who to short, but we don't know whether it's even looked, but you know, you get a CSV on my PC which literally just the other a power line and scorched my PSU which access to the CSV files of a closed know buying some puts this morning like you can make that yield by buying VG for calls from people trying to give me

View source
Good Afternoon.
InTheMoney · Apr 30, 2026, 9:50 PM EDT

The entry is almost entirely promotional text and legal disclaimers for a YouTube/X/Discord investing-related channel and Autopilot relationship disclosure. It contains no substantive market view, company-specific information, portfolio positions, industry intelligence, or trade rationale.

View source
How to Manage LEAPS - a MUST watch (previously private, making public)
InTheMoney · Apr 15, 2026, 8:00 PM EDT

Promotional post for a paid service/video about managing LEAPS (long-dated options), with links to try a product and copy portfolios. No specific market news, catalysts, positions, or tickers disclosed.

View source
im back (again fr fr i think)
InTheMoney · Apr 15, 2026, 8:00 PM EDT

Skipped non-finance YouTube video. The content does not contain a clear market or investable-stock discussion.

View source
Autopilot and Investing Soldiers: Sit Down and Listen Up, GI
InTheMoney · Mar 31, 2026, 8:42 AM EDT

Promotional/disclaimer post advertising an “Autopilot” copy-trading/portfolio mirroring platform and a paid membership/alerts service. Contains affiliate links and general investing-risk disclaimers, but no company-specific news, financial results, macro data, or actionable trading catalyst tied to any publicly traded ticker.

View source

Supporting authors

Single author. Posts are mainly promotional and disclaimer-heavy; the only substantive market commentary comes from the author’s personal update noting a small Nasdaq-100 dip and recommending calm/risk-on posture.

Unlock full thesis monitoring

Maintain risk-on exposure to the Nasdaq-100 during this modest pullback. Use QQQ for core exposure, consider TQQQ only if you expect a quick rebound and can tolerate high volatility, and be cautious with inverse exposure such as SQQQ.